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Abstract
Background:  Gallbladder cancer is a common neoplasm of biliary tract, with an unknown
etiology.
Patients and methods: This study was carried out to evaluate the changes in the membrane fatty
acid profile and saturation index in patients with gallbladder cancer. The study sample consisted of
50 newly diagnosed cases of gallbladder cancer and 50 patients undergoing cholecystectomy for
cholelithiasis were recruited as controls. The fatty acid estimation was carried out by high
performance liquid chromatography (HPLC). Statistical analysis was carried out by student 't' test
and one-way ANOVA. Pearson's correlation coefficient was also obtained.
Results: A significant lowering of erythrocyte membrane stearic acid (p = 0.000), arachidonic acid
(p = 0.001), and saturation index (p = 0.001) was observed in patients with gallbladder cancer
compared to controls. A significant inverse relation was observed between stearic and oleic acid
(r = -0.269 p = 0.007).
Conclusion: Results of the present study suggest an increase in the delta 9 desaturation in cancer
patients compared to controls however, a possible role of biliary stasis due to altered gallbladder
motility or derangements of signal transduction secondary to altered membrane lipid bilayer cannot
be ruled out.
Introduction
Fatty acids are long chain organic acids and form a major
component of membrane lipids. A membrane fatty acid
profile is thought to reflect the body composition as well
as dietary fat intake [1]. Of these, polyunsaturated fatty ac-
ids (PUFA) are prone to free radical attack and hydrogen
abstraction, the oxidative damage being termed as lipid
peroxidation [2]. This causes a reduction in the mem-
brane fluidity and permeability [2]. These changes in the
lipid bilayer are also thought to interfere with the electron
transport chain and signal transduction across the cellular
membrane.
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Stearic acid is an 18C saturated fatty acid, which is con-
verted into delta 9 monounsaturated 18C oleic acid by the
liver microsomal desaturase system [3]. An increase in
delta 9 desaturation and lowering of saturation index has
been observed in colorectal cancer [4], bronchogenic car-
cinoma [5], lymphoma [6], leukemia [7], malignant liver
neoplasms [8,9] as well as in gallbladder cancer [10].
Hence on one hand the saturation index might prove to
be a diagnostic marker of malignancy, the fatty acid pro-
file changes might provide a clue to carcinogenesis. We
carried out this case-control study to evaluate the fatty
acid profile and saturation index in patients with carcino-
ma of the gallbladder and cholelithiasis.
Material and Methods
This case-control study was carried out at University Hos-
pital, Varanasi, cases constituted 50 newly diagnosed gall-
bladder cancer, while another 50 patients undergoing
cholecystectomy for cholelithiasis constituted controls.
Five milliliter of venous blood was collected in
heparinized vials and was centrifuged at 10,000 rpm for 5
minutes to separate erythrocytes. These were washed twice
with phosphate buffer saline and centrifuged, the super-
natant was decanted and erythrocytes were stored at -
20°C till further analysis.
Erythrocytes were thawed and 2 ml of distilled water was
added to hemolyze the erythrocytes. The hemolyzed solu-
tion was saponified by refluxing with N/2 alcoholic KOH
in water bath and the fatty acids were extracted in ether.
Remaining saponified matter was acidified with 10% HCl
and extracted with ether. The ether extract was washed
with distilled water till acid free, dried under anhydrous
sodium sulphate to obtain free fatty acids. These were
then converted to fatty acid methyl esters (FAME) by
methylating with methanol sulphuric acid. The mixture
was heated in water bath for 4 hours, cooled to room tem-
perature and then extracted with ether. The ether soluble
layer was washed with 1% KOH and then by distilled wa-
ter till alkali free. The ether was evaporated and FAME
were dissolved in benzene and stored at 4°C till analysis.
For chromatographic analysis 100 µg of FAME, 10 ml of
Phenacyl bromide solution and 10 µl of triethylamine so-
lution were combined and allowed to stand overnight at
room temperature. An aliquot of this solution was inject-
ed directly into liquid chromatograph. High performance
liquid chromatography was carried out using Waters 680
AGC chromatograph equipped with Water's 501 pump
solvent programmer and Waters UV detector. Absorbance
was measured at 254 nm. A 90 cm × 0.64 cm : bondapak
C-18 column was used with acetonitrite (8:20 v/v) as elu-
ent at a flow rate of 0.50 ml / minute.
Statistical analysis was carried out by student 't' test and
one-way ANOVA (F). Pearson's correlation coefficients (r)
were also calculated.
Results
The mean age of the patients with cholelithiasis was 41.8
± 10.0 years (range 24–60) and 49.8 ± 9.5 years (range
34–67) for cancer patients, majority of the patients in
both groups were females (88 and 90% of cancer and
stones respectively).
A significant lowering of the erythrocyte membrane stear-
ic acid and arachidonic acid levels was observed in pa-
tients with carcinoma of the gallbladder compared to
controls (p = 0.000 and p = 0.001 respectively) (Table 1).
Lowering was also observed in the levels of lauric acid,
palmitic acid and palmitoleic acid, however, this was sta-
tistically not significant. On the other hand an increase in
the concentration of oleic acid (C 18:1) was observed in
patients with carcinoma of the gallbladder, however, this
too was statistically not significant (p = 0.22).
A significant lowering in the saturation index (SI), which
is defined as stearic to oleic acid ratio, was observed in pat-
Table 1: Erythrocyte fatty acid concentration (mean and Standard deviation) in cholelithiasis and carcinoma of the gallbladder (figure 
in parenthesis is range)
Fatty acid Cancer (n = 50) Gallstones (n = 50) Test value respective P value
C 12:0 Lauric Acid 5.0 ± 6.7 (0–18.4) 6.8 ± 7.3 (0–20.4) t = 1.27 F = 1.62 0.20, 0.21
C 14:0 Myristic Acid 3.5 ± 3.0 (0–10.1) 3.8 ± 3.6 (0–11.1) t = 0.45 F = 0.21 0.64, 0.65
C 16:0 Palmitic Acid 8.6 ± 5.0 (0–16.4) 9.4 ± 5.8 (0–19.6) t = 0.77 F = 0.59 0.44, 0.44
C 16:1 Palmitoleic Acid 2.05 ± 2.7 (0–8.4) 3.6 ± 9.0 (0–47.0) t = 1.22 F = 1.49 0. 22, 0. 22
C 18:0 Stearic Acid 23.6 ± 23.0 (0–76.0) 45.57 ± 24.1 (0–90.8) t = 4.65 F = 21.6 0. 000, 0. 0000
C 18:1 Oleic Acid 24.2 ± 21.6 (0–92.8) 19.8 ± 14.1 (0–35.2) t = 1.2 F = 1.4 0. 22, 0. 22
C 20:4 Arachidonic Acid 9.08 ± 16.6 (0–80.0) 24.3 ± 28.2 (0–82.12) t = 3.2 F = 10.74 0. 001, 0. 0014
Saturation Index 0.08 ± 1.2 (0–4.4) 2.0 ± 1.8 (0–8.5) t = 3.45 F = 11.9 0. 001, 0. 0009
F = one-way Anova value; t = student 't' test value; p = probability value.World Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/5
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ents with carcinoma of the gallbladder compared to pa-
tients with cholelithiasis (t = 3.45 p = 0.001; F = 11.9, p =
0.0009).
Pearson's correlation analysis showed lauric acid (r = -
0.239, p = 0.01) and arachidonic acid (r = -0.256 p = 0.01)
to be negatively correlated with age. The stearic acid levels
significantly correlated with lauric acid (r = -0.27, p =
0.007), palmitoleic acid (r = -0.225 p = 0.025) and oleic
acid (r = -0.269 p = 0.007) (Table 2).
Discussion
The results of the present study show a reduction in Satu-
ration Index (SI) in patents with gallbladder cancer com-
pared to controls. However, in preliminary study [9], this
fall in SI was primarily due to fall in the content of stearic
acid and increase in oleic acid in patients with carcinoma
of the gallbladder. We did not observe a significant rise in
the level of oleic acid in carcinoma patients, however, fall
in the levels of stearic acid were significant in this study.
This change in SI was similar to earlier observations by
other authors at various cancer sites [4–8]. The Kelly's
concept that "cancer is a systemic disease and that the de-
crease in SI is not type specific but is associated with neo-
plasia" is a supported by the present results as well. [4,10]
Similar to the results of our earlier study [11], the present
study too show a fall in concentration of arachidonic acid
in patients with gallbladder cancer, compared to patients
with cholelithiasis, however, absence of a normal control
group preclude the exact interpretation of this observa-
tion. Although not much delta 9 desaturation was seen in
the present study when compared to the results of our ear-
lier study [11], however this may be due to less number of
patients in our earlier study and high variance thus ob-
served. We had earlier proposed a role of free radical me-
diated lipid peroxidation in gallbladder carcinogenesis,
however, our attention was subsequently drawn to the re-
lationship of lipid peroxidation product 4-hydroxynone-
nal (HNE) and electrolytes suggesting that increase in
lipid peroxidation products was probably due to in-
creased stasis rather than increased peroxidation [12].
Even though the concentration of biliary lipid peroxides
were not measured in the present study the fatty acid pro-
file changes observed here probably indicate mechanism
other than lipid peroxidation in gallbladder carcinogene-
sis. This could either be due to altered motility and con-
centration of carcinogens in gallbladder as proposed by us
earlier [13] or by altered signal transduction brought
about by a change in lipid bilayer. We are presently carry-
ing out the lipid peroxide product maelonaldehyde
(MDA) estimation in the frozen gallbladder tissue of the
same patients reported here, and presume that will not
only throw additional light but might be able to answer
the question of probable role of lipid peroxidation in gall-
bladder carcinogenesis.
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